Glucose Metabolism Is Required for Oxidized LDL-Induced Macrophage Survival Role of PI3K and Bcl-2 Family Proteins

被引:18
作者
Elsegood, Caryn L. [1 ,2 ]
Chang, Margaret [1 ,2 ]
Jessup, Wendy [3 ]
Scholz, Glen M. [1 ,2 ]
Hamilton, John A. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Arthrit & Inflammat Res Ctr, Parkville, Vic 3050, Australia
[2] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Res Ctr Chron Inflammatory Dis, Parkville, Vic 3050, Australia
[3] Univ New S Wales, Macrophage Biol Grp, Ctr Vasc Res, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
macrophage; oxidized LDL; glucose; survival; Bcl-2 family proteins; LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROTIC PLAQUE; 3T3-L1; ADIPOCYTES; SIGNALING PATHWAY; GROWTH-FACTORS; CELL-DEATH; APOPTOSIS; ACTIVATION; EXPRESSION; TRANSPORT;
D O I
10.1161/ATVBAHA.108.180778
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective-Oxidized low-density lipoprotein (oxLDL) induces survival of colony stimulating factor-1 (CSF-1)-dependent macrophages in vitro. Because atherosclerotic lesion-associated macrophages take up large amounts of glucose, we investigated whether, and how, oxLDL promotes glucose uptake and how glucose metabolism regulates oxLDL-induced macrophage survival. Methods and Results-OxLDL-induced macrophage survival required glucose metabolism. OxLDL stimulated 2 phases of glucose uptake, namely acute and chronic, which required PI3K but not MEK1/2 activity. PI3K appeared to regulate glucose transport via glucose transporter affinity and/or mobilization. OxLDL also maintained levels of the prosurvival proteins, Bcl-2 and Bcl-x(L), after CSF-1 had been removed through a combination of mechanisms including transcription, translation, and protein stabilization. Significantly, inhibition of glucose metabolism reduced Bcl-2 and Bcl-x(L) protein levels. MEK1/2 and PI3K activities were also required for oxLDL-induced Bcl-2 and Bcl-xL mRNA upregulation. Conclusions-These results suggest that oxLDL enhances macrophage survival in the absence of CSF-1 by inducing PI3K-dependent glucose uptake, which is metabolized to maintain Bcl-2 and Bcl-x(L) protein levels. (Arterioscler Thromb Vasc Biol. 2009;29:1283-1289.)
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 40 条
[1]
The vulnerable atherosclerotic plaque - Pathogenesis and therapeutic approach [J].
Aikawa, M ;
Libby, P .
CARDIOVASCULAR PATHOLOGY, 2004, 13 (03) :125-138
[2]
A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development [J].
Arai, S ;
Shelton, JM ;
Chen, MY ;
Bradley, MN ;
Castrillo, A ;
Bookout, AL ;
Mak, PA ;
Edwards, PA ;
Mangelsdorf, DJ ;
Tontonoz, P ;
Miyazaki, T .
CELL METABOLISM, 2005, 1 (03) :201-213
[3]
MACROPHAGES SPECIFICALLY REGULATE THE CONCENTRATION OF THEIR OWN GROWTH-FACTOR IN THE CIRCULATION [J].
BARTOCCI, A ;
MASTROGIANNIS, DS ;
MIGLIORATI, G ;
STOCKERT, RJ ;
WOLKOFF, AW ;
STANLEY, ER .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6179-6183
[4]
BIRD TA, 1990, J BIOL CHEM, V265, P13578
[5]
Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway [J].
Breitschopf, K ;
Haendeler, J ;
Malchow, P ;
Zeiher, AM ;
Dimmeler, S .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) :1886-1896
[6]
Phosphatidylinostitol-3 kinase and phospholipase C enhance CSF-1-dependent macrophage survival by controlling glucose uptake [J].
Chang, Margaret ;
Hamilton, John A. ;
Scholz, Glen M. ;
Masendycz, Paul ;
Macaulay, S. Lance ;
Elsegood, Caryn L. .
CELLULAR SIGNALLING, 2009, 21 (09) :1361-1369
[7]
Colony-stimulating factor-1 in immunity and inflammation [J].
Chitu, V ;
Stanley, ER .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :39-48
[8]
CLANCY BM, 1991, J BIOL CHEM, V266, P10122
[9]
Controlling cell growth and survival through regulated nutrient transporter expression [J].
Edinger, Aimee L. .
BIOCHEMICAL JOURNAL, 2007, 406 :1-12
[10]
Energy metabolism during apoptosis - bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest [J].
Garland, JM ;
Halestrap, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :4680-4688